Manufacturing

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

Increasingly complex trial protocols have added to IMP manufacturing challenges.

Clinical Manufacturing: Clearing Higher Hurdles

Experts from the Partnership for Research on Ebola VACcination report on progress and uncertainties regarding a safe and effective Ebola vaccine.

Experts Reveal Ebola Vaccine Status and Potential

The National Institute of Allergy and Infectious Diseases began a first-in-human trial of an experimental live, attenuated Zika virus vaccine.

Zika Vaccine Clinical Trial Begins

Researchers at the National Cancer Institute have developed a new approach to immunotherapy that led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments.

New Immunotherapy Method Brings Complete Regression of Hard-to-Treat Breast Cancer

Demand for direct-to-patient services is exploding. Michael Sweeney, senior director of patient-centric logistics at World Courier, discusses issues that the new model presents. 

Meeting the Challenge of Patient-Centered Clinical Trials

Catalent’s GPEx technology was used to develop antibody for anti-methamphetamine clinical study.

Anti-methamphetamine Antibody Moves to Clinic

The second phase of a $5.5-million expansion adds controlled-substance and controlled-temperature storage to Catalent clinical trials facility.

Catalent Adds Capacity at Kansas City Clinical Supplies Facility

Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.

Catalent to Develop Biosimilars for Valerius Biopharma

A $5.5-million expansion at its Philadelphia, PA clinical supplies facility gives Catalent additional packaging and storage capacity.

Catalent Adds Clinical Supplies Capacity

An expanded pharma services supply chain facility in Germany boosts Thermo Fisher’s Pharma Services footprint in Europe.

Clinical Trial Materials